Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.
Benefits
Due to legal reasons we are obliged to disclose the minimum salary for this position, which is 23.722,02 gross per year based on full-time employment. However, our salaries are market oriented and in line with your qualifications and experience.